Comparing insulin vs oral diabetes pills after heart attack stenting
Part of Hormones & metabolism clinical trials.
This trial compares how well people with type 2 diabetes recover after a heart attack treated with a stent procedure, based on whether they were on insulin or oral diabetes pills before the heart attack. The goal is to see if one type of diabetes treatment leads to better short-term outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes and are 18 or older
- You had a type of heart attack called STEMI and are getting a stent procedure (primary PCI) within the trial timeframe
- Before the heart attack, you were taking either insulin or oral diabetes pills, but not both
- You do not have type 1 diabetes, severe kidney disease (eGFR below 30), or had prior bypass surgery
- You are not planned to switch from oral pills to insulin during the follow-up period
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares how chest pain feels in people with and without diabetes after a heart attack. It aims to understand if diabetes changes the symptoms, which could help doctors diagnose faster.
This study measures how your body handles sugar and related hormones in people after a new STEMI heart attack, and compares them with people who do not have diabetes or have prediabetes. The goal is to better understand metabolic changes after the event, which could help future care.
This study compares using a special medicated balloon plus a medicated stent versus using just one of them to open blocked heart arteries in people with diabetes. It aims to find which treatment works better to keep arteries open longer.
This study looks at whether insulin resistance (when the body doesn't use insulin well) is linked to poor blood flow after a stent procedure in people with type 2 diabetes who have had a heart attack. It might help doctors understand why some people have worse outcomes after this treatment.
This study compares two ways to restore blood flow to the heart—stent placement (PCI) versus bypass surgery (CABG)—in people with diabetes and significant multi-vessel coronary artery disease. It looks at outcomes using both standard heart tests and additional imaging/functional measurements to guide the best revascularization strategy.
This trial compares two ways to guide heart stent placement in people with diabetes. One method uses a special camera inside the artery (IVI), the other uses standard X-ray pictures. The goal is to see which leads to better outcomes.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.